[{"Assets_0_Q1_USD":664468000.0,"CommonStockSharesOutstanding_0_Q1_shares":43821247.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-49563000.0,"NetIncomeLoss_1_Q1_USD":-56549000.0,"StockholdersEquity_0_Q1_USD":570873000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":43700226.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":43700226.0,"Ticker":"BPMC","CIK":"1597264","name":"BLUEPRINT MEDICINES CORP","OfficialName":"Blueprint Medicines Corporation Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3980842399.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180502"}]